Ryvu Therapeutics S.A. (WSE:RVU)
Poland
· Delayed Price · Currency is PLN 31.55
-0.85 (-2.62%)
Apr 24, 2025, 3:41 PM CET
Ryvu Therapeutics Market Cap
Ryvu Therapeutics has a market cap or net worth of 749.09 million as of April 24, 2025. Its market cap has decreased by -40.66% in one year.
Market Cap
749.09M
Enterprise Value
633.69M
Revenue
101.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
31.55
Market Cap Chart
Since July 14, 2011, Ryvu Therapeutics's market cap has increased from 56.50M to 749.09M, an increase of 1,225.75%. That is a compound annual growth rate of 20.62%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NEUCA | 3.04B |
| Synektik Spólka Akcyjna | 1.74B |
| Voxel | 1.45B |
| Celon Pharma | 1.30B |
| Bioceltix | 586.01M |
| Selvita | 558.01M |
| Centrum Medyczne ENEL-MED | 551.47M |
| Scope Fluidics | 487.40M |